Gucunga neza neza CML: Uruhare rukomeye rwa BCR-ABL Kumenya mugihe cya TKI

Ubuyobozi bwa karande Myelogenous Leukemia (CML) bwahinduwe na Tyrosine Kinase Inhibitor (TKIs), bihindura indwara yigeze guhitana abantu ihinduka indwara idakira. Intandaro yiyi nkuru intsinzi ibeshya neza kandi yizewe yaBCR-ABL fusion gene-Umushoferi wuzuye wa CML.

Kurenga kwisuzumisha ryambere, ingano ya BCR-ABL niyo nkingi yo gucunga neza abarwayi ubuzima bwabo bwose. Itanga abaganga amakuru yingenzi akenewe:

Shiraho Ibanzemugusuzuma.

Suzuma igisubizo cyo kuvura hakiri kareno guhanura ibizagerwaho igihe kirekire.

Kuyobora Ubuvuzi bwa TKIbishingiye kuri molekile yo gusubiza.

Gukurikirana Indwara Zisigaye (MRD)n'ibishobora gusubira inyuma.

Ariko,Kumenya kutizewe birashobora guhungabanya ibyo byemezo.

Macro & Micro-Ikizamini's Umuntu BCR-ABL Fusion Gene Mutation Detection Kitni injeniyeri kugirango itange ibisobanuro bisabwa kubwizere kuri buri cyiciro.

Impamvu Igisubizo Cyacu ari Umufatanyabikorwa Wizewe muri CML Kwitaho:

1. Umwirondoro wuzuye:Icyarimwe kumenya inyandiko eshatu zingenzi za BCR-ABL (P210, P190, P230), kugirango hatabaho urubanza rukomeye rwabuze.
2. Ibyiyumvo bitagereranywa:Kugera kumupaka wo gutahura (LoD) hasi nkuko1.000 kopi / mL, itanga isuzuma hakiri kare kandi ryukuri ryibisubizo byimbitse.
3. Ukuri gukomeye:Harimo igenzura ryimbere hamwe na sisitemu ya enzyme ya UNG kugirango ikureho ibyiza / ibibi, kurinda ubusugire bwibisubizo.
4. Urujya n'uruza rw'akazi:Ibiranga umuyoboro ufunze, nyuma ya PCR-yubusa, gutanga ibisubizo bifatika muminota 60 kugirango byihute gufata ibyemezo byubuvuzi.
5. Guhindura imikorere:Gutangwa muburyo bwamazi na anofilize kugirango bihuze laboratoire zitandukanye.
   
   Emera igipimo cya zahabu mugukurikirana molekile. Ongera ivuriro ryawe hamwe nibisobanuro bikenewe kugirango utezimbere ubuzima bwawe bwose kubarwayi bawe ba CML.

   Menyesha amakuru arambuye:marketing@mmtest.com